Cart
sales@molnova.com
HJC0350
CAS No. 885434-70-8
HJC0350( HJC 0350 | HJC0350 | HJC-0350 )
Catalog No. M19231 CAS No. 885434-70-8
HJC0350 is an effective and specific EPAC2 inhibitor (IC50: 0.3 μM), and no inhibition of Epac1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 125 | In Stock |
|
| 50MG | 205 | In Stock |
|
| 100MG | 354 | In Stock |
|
| 200MG | 527 | In Stock |
|
| 500MG | 843 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHJC0350
-
NoteResearch use only, not for human use.
-
Brief DescriptionHJC0350 is an effective and specific EPAC2 inhibitor (IC50: 0.3 μM), and no inhibition of Epac1.
-
DescriptionHJC 0350 is a selective Epac2 inhibitor (IC50 = 0.3 μM). HJC 0350 displays no effect on Epac1. HJC 0350 blocks stimulation of the Epac2-FL FRET sensor in HEK293 cells.
-
In VitroHJC0350 has an apparent IC50 value of 0.3 μM for competing with 8-NBD-cAMP binding of EPAC2, and is about 133-fold more potent than cAMP. HJC0350 is found not to inhibit EPAC1-mediated Rap1-GDP exchange activity at 25 μM in the presence of equal concentration of cAMP, indicating that it is EPAC2-specific antagonists. Pretreatment of HEK293/EPAC2-FL cells with 10 μM HJC0350 fully blocks the 007-AM induced decrease of FRET.
-
In Vivo——
-
SynonymsHJC 0350 | HJC0350 | HJC-0350
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorEPAC2
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number885434-70-8
-
Formula Weight277.38
-
Molecular FormulaC15H19NO2S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 33.33 mg/mL 120.16 mM
-
SMILESCc1cc(c(c(c1)C)S(=O)(=O)n1cc(cc1C)C)C
-
Chemical Name2,4-dimethyl-1-(2,4,6-trimethylphenyl)sulfonylpyrrole
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chen H, et al. J Med Chem. 2013, 56(3), 952-962.
molnova catalog
related products
-
NF-κΒ activator 2
NF-κΒ activator 2 is a potent and orally active NF-κB activator, with an EC 50 of 1.58 μM. NF-κΒ activator 2 induces SOD 2 through increasing NF-κB expression and activation. NF-κΒ activator 2 can be used for the research of amyotrophic lateral sclerosis (ALS) .
-
GGTI 2147
GGTI 2147 decreased Rac1 activity, down-regulated p65 expression, and ameliorated OGD/R-induced neuronal apoptosis.
-
Amgen16
Amgen 16 (Amgen16) is a highly potent inhibitor of NF-κB inducing Kinase (NIK) with Ki of 2 nM.
